Find help paying for treatment

Adbry Advocate Copay Program

Commercial copay assistance from the manufacturer of Adbry. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

LEO Pharma Patient Assistance Program

Patient Assistance Program from the manufacturer of Adbry. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Anzupgo Advocate Copay Program

Commercial copay assistance for Anzupgo (delgocitinib cream), a topical pan-JAK inhibitor FDA-approved for moderate-to-severe chronic hand eczema in adults when topical corticosteroids are inadequate.

LEO Pharma Patient Assistance Program

Patient Assistance Program from the manufacturer of Anzupgo. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

BIMZELX Navigate Copay Program

Commercial copay assistance from the manufacturer of Bimzelx. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

UCB Patient Assistance Program (ucbCARES)

Patient Assistance Program from the manufacturer of Bimzelx. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Cibinqo Savings Card

Commercial copay assistance from the manufacturer of Cibinqo. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

Pfizer Patient Assistance Program (Pfizer RxPathways)

Patient Assistance Program from the manufacturer of Cibinqo. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

CIMplicity Copay Program

Commercial copay assistance from the manufacturer of Cimzia. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

UCB Patient Assistance Program (ucbCARES)

Patient Assistance Program from the manufacturer of Cimzia. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Cosentyx Connect Personal Support Program (Copay)

Commercial copay assistance from the manufacturer of Cosentyx. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

Novartis Patient Assistance Foundation

Patient Assistance Program from the manufacturer of Cosentyx. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Cosentyx Quick Start / Bridge Program

Free short-term supply of Cosentyx while your insurance reviews the prior authorization or appeal. Designed to prevent treatment delays.

Dupixent MyWay Copay Card

Commercial copay assistance from the manufacturer of Dupixent. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

Dupixent MyWay Patient Assistance Program

Patient Assistance Program from the manufacturer of Dupixent. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Dupixent Quick Start / Bridge Program

Free short-term supply of Dupixent while your insurance reviews the prior authorization or appeal. Designed to prevent treatment delays.

Ebglyss Savings Card

Commercial copay assistance from the manufacturer of Ebglyss. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

Lilly Cares Foundation Patient Assistance Program

Patient Assistance Program from the manufacturer of Ebglyss. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Enbrel Support Copay Card

Commercial copay assistance from the manufacturer of Enbrel. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

Amgen Safety Net Foundation

Patient Assistance Program from the manufacturer of Enbrel. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Eucrisa Savings Card

Commercial copay assistance for Eucrisa (crisaborole), a non-steroid topical PDE4 inhibitor for mild-to-moderate atopic dermatitis in patients 3 months and older.

Pfizer Patient Assistance Program (Pfizer RxPathways)

Patient Assistance Program from the manufacturer of Eucrisa. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Humira Complete Savings Card

Commercial copay assistance from the manufacturer of Humira. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

myAbbVie Assist Patient Assistance Foundation

Patient Assistance Program from the manufacturer of Humira. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Adalimumab biosimilar copay programs

Each adalimumab biosimilar manufacturer offers its own copay savings program for commercially insured patients. Programs typically reduce out-of-pocket costs to as little as $0–$5 per month and are often coordinated through the specialty pharmacy dispensing your product.

Adalimumab biosimilar Patient Assistance Programs

Each adalimumab biosimilar manufacturer runs a Patient Assistance Program for uninsured patients or those with unaffordable government-plan cost-sharing. Eligibility is income-based and varies by manufacturer.

Icotyde withMe Savings Program

Commercial copay assistance from Johnson & Johnson for Icotyde (icotrokinra), the first oral IL-23 receptor antagonist peptide for moderate-to-severe plaque psoriasis. Eligible commercially insured patients may pay as little as $0 per month.

Johnson & Johnson Patient Assistance Foundation

Patient Assistance Program from the manufacturer of Icotyde. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Icotyde Quick Start / Bridge Program

Free short-term supply of Icotyde while your insurance reviews the prior authorization or appeal. Designed to prevent treatment delays.

ILUMYA Support Copay Program

Commercial copay assistance from the manufacturer of Ilumya. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

ILUMYA Patient Assistance Program

Patient Assistance Program from the manufacturer of Ilumya. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Leqselvi Copay Savings Program

Commercial copay assistance from the manufacturer of Leqselvi. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

Sun Pharma Patient Assistance Program

Patient Assistance Program from the manufacturer of Leqselvi. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Litfulo Savings Card

Commercial copay assistance from the manufacturer of Litfulo. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

Pfizer Patient Assistance Program (Pfizer RxPathways)

Patient Assistance Program from the manufacturer of Litfulo. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Nemluvio Copay Savings Program

Commercial copay assistance from the manufacturer of Nemluvio. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

Galderma CareConnect Patient Assistance Program

Patient Assistance Program from the manufacturer of Nemluvio. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Olumiant Together Savings Card

Commercial copay assistance from the manufacturer of Olumiant. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

Lilly Cares Foundation Patient Assistance Program

Patient Assistance Program from the manufacturer of Olumiant. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Opzelura Copay Savings Card

Commercial copay assistance from the manufacturer of Opzelura. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

IncyteCARES Patient Assistance Program

Patient Assistance Program from the manufacturer of Opzelura. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Otezla Copay Card

Commercial copay assistance from the manufacturer of Otezla. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

Amgen Safety Net Foundation

Patient Assistance Program from the manufacturer of Otezla. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Otezla Quick Start / Bridge Program

Free short-term supply of Otezla while your insurance reviews the prior authorization or appeal. Designed to prevent treatment delays.

Rinvoq Complete Savings Card

Commercial copay assistance from the manufacturer of Rinvoq. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

myAbbVie Assist Patient Assistance Foundation

Patient Assistance Program from the manufacturer of Rinvoq. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Rituxan Co-pay Program (Genentech)

Commercial copay assistance for Rituxan (rituximab) infusions, FDA-approved as first-line therapy for moderate-to-severe pemphigus vulgaris.

Genentech Patient Foundation

Patient Assistance Program from the manufacturer of Rituxan. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Siliq Copay Program

Commercial copay assistance for Siliq (brodalumab), an IL-17 receptor antagonist for moderate-to-severe plaque psoriasis. Siliq is dispensed only through the SILIQ REMS Program because of its boxed warning for suicidal ideation and behavior.

Bausch Health Patient Assistance Program (Bausch Patient Access)

Patient Assistance Program from the manufacturer of Siliq. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Skyrizi Complete Savings Card

Commercial copay assistance from the manufacturer of Skyrizi. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

AbbVie Patient Assistance Foundation (myAbbVie Assist)

Patient Assistance Program from the manufacturer of Skyrizi. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Skyrizi Quick Start / Bridge Program

Free short-term supply of Skyrizi while your insurance reviews the prior authorization or appeal. Designed to prevent treatment delays.

Sotyktu 360 Support Copay Card

Commercial copay assistance from the manufacturer of Sotyktu. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

BMS Patient Assistance Foundation

Patient Assistance Program from the manufacturer of Sotyktu. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Stelara withMe Savings Program

Commercial copay assistance from the manufacturer of Stelara. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

Johnson & Johnson Patient Assistance Foundation

Patient Assistance Program from the manufacturer of Stelara. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Stelara Quick Start / Bridge Program

Free short-term supply of Stelara while your insurance reviews the prior authorization or appeal. Designed to prevent treatment delays.

Ustekinumab biosimilar copay programs

Each ustekinumab biosimilar manufacturer offers a copay savings program for commercially insured patients with plaque psoriasis or psoriatic arthritis. Programs typically bring out-of-pocket cost down to as little as $5 per dose.

Ustekinumab biosimilar Patient Assistance Programs

Each ustekinumab biosimilar manufacturer runs a Patient Assistance Program for uninsured patients or those with unaffordable government-plan cost-sharing. Eligibility is income-based and varies by manufacturer.

Taltz Together Savings Card

Commercial copay assistance from the manufacturer of Taltz. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

Lilly Cares Foundation Patient Assistance Program

Patient Assistance Program from the manufacturer of Taltz. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Taltz Quick Start / Bridge Program

Free short-term supply of Taltz while your insurance reviews the prior authorization or appeal. Designed to prevent treatment delays.

Tremfya withMe Savings Program

Commercial copay assistance from the manufacturer of Tremfya. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

Johnson & Johnson Patient Assistance Foundation

Patient Assistance Program from the manufacturer of Tremfya. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Tremfya Quick Start / Bridge Program

Free short-term supply of Tremfya while your insurance reviews the prior authorization or appeal. Designed to prevent treatment delays.

Vtama Copay Savings Program

Commercial copay assistance from the manufacturer of Vtama. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

Organon Patient Assistance Program

Patient Assistance Program from the manufacturer of Vtama. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Xolair Co-pay Program

Commercial copay assistance from the manufacturer of Xolair. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

Genentech Patient Foundation

Patient Assistance Program from the manufacturer of Xolair. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.

Zoryve Direct Copay Program

Commercial copay assistance from the manufacturer of Zoryve. Eligible commercially insured patients may pay as little as $0–$5 per dose, up to a yearly maximum.

Arcutis Cares Patient Assistance Program

Patient Assistance Program from the manufacturer of Zoryve. Provides medication at no cost to qualifying patients who are uninsured or whose insurance (including Medicare or Medicaid) does not adequately cover the drug.